The Eye Care Blog

The Hodkin Kopelowitz Ostrow Firm, P.A. (THKO) announced that it filed a federal class action lawsuit last week in Fort Lauderdale, Florida, against Bausch & Lomb, Inc.

A Bausch & Lomb product, ReNu with MoistureLoc contact lens solution, is being investigated for potential ties to a rare fungal eye infection known as Fusarium Keratitis. The class action lawsuit has been filed on behalf of all persons in the United States who have used the solution; although the firm has been contacted by hundreds of former users from across the United States and Mexico who suffered eye infections from using the solution. THKO is already representing many of them and expects to file a significant number of additional cases in the next few weeks.

THKO has set up the web site www.renulitigation.com as a way for consumers affected by the contact lens solution to contact the law firm and to learn more about their legal rights and pending litigation. THKO may also be reached Toll-Free at 877-525-4100.

Link

Filed under Contact Lens, Eye Treatment

You may also like to read

• Bausch & Lomb Facing US. Federal Lawsuit Over ReNu Contact Lens Solution
• Fusarium Keratitis Fungal Infection - ReNu Contact Lens Solution Link Confirmed By Bausch and Lomb
• Bausch & Lomb Facings Class Action Lawsuit for Fusarium Kerititus - Renu Link
• Fusarium Kerititus (Fungal Eye Infection) Hit Berks County
• MoistureLoc Contact Lens Solution ( Lead To Fusarium Keratitis Infection ) Solution Maker Sues Insurance Company
• Basuch & Lomb (Fusarium Keratitis Fiasco) Was Cited in 2002 for Quality Control Problems
• Bausch & Lomb Permanently Removes ReNu With MoistureLoc Product Worldwide
• FDA To Review US Contact Lens Cleaners After Fusarium Keratitis & Acanthamoeba Parasite Infections
• Bausch & Lomb Urging Soft Contact-Lens Wearers To Stop Using ReNu
• Fusarium Keratitis (Contact Lens Fungal Infection) Linked To ReNu Contact Lens Solution From Bausch & Lomb

This entry was posted on Thursday, June 1st, 2006 at 8:58 am. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.